Poor glycemic control enhances the disease activity in the RA patients with undiagnosed diabetes—a cross-sectional clinical study

Abstract Background Rheumatoid arthritis (RA), an autoimmune disorder, characterized by systemic inflammation and swollen joints, establishes itself as a critical threat. A pro-inflammatory cytokine TNF-α is a well-known driver of RA pathogenesis and at the same time predisposes to insulin resistanc...

Full description

Bibliographic Details
Main Authors: Pulak Kanti Palit, Ashekul Islam, Md Syeed Al Habib, Abu Syed Mohammed Mujib, Joyonti Datta, Bahni Chakraborty, Suman Dhar, Dhiman Chowdhury, Md Faisal Fahad Chowdhury, Mohammad Shawkat Ali, Arfana Yesmin, Mohammod Johirul Islam, Nishat Akther, Abdullah Al Mamun, Khairul Islam, Pradip Kumar Nath
Format: Article
Language:English
Published: SpringerOpen 2021-12-01
Series:Egyptian Rheumatology and Rehabilitation
Subjects:
Online Access:https://doi.org/10.1186/s43166-021-00097-8
_version_ 1798026818880536576
author Pulak Kanti Palit
Ashekul Islam
Md Syeed Al Habib
Abu Syed Mohammed Mujib
Joyonti Datta
Bahni Chakraborty
Suman Dhar
Dhiman Chowdhury
Md Faisal Fahad Chowdhury
Mohammad Shawkat Ali
Arfana Yesmin
Mohammod Johirul Islam
Nishat Akther
Abdullah Al Mamun
Khairul Islam
Pradip Kumar Nath
author_facet Pulak Kanti Palit
Ashekul Islam
Md Syeed Al Habib
Abu Syed Mohammed Mujib
Joyonti Datta
Bahni Chakraborty
Suman Dhar
Dhiman Chowdhury
Md Faisal Fahad Chowdhury
Mohammad Shawkat Ali
Arfana Yesmin
Mohammod Johirul Islam
Nishat Akther
Abdullah Al Mamun
Khairul Islam
Pradip Kumar Nath
author_sort Pulak Kanti Palit
collection DOAJ
description Abstract Background Rheumatoid arthritis (RA), an autoimmune disorder, characterized by systemic inflammation and swollen joints, establishes itself as a critical threat. A pro-inflammatory cytokine TNF-α is a well-known driver of RA pathogenesis and at the same time predisposes to insulin resistance through signal impediment which ultimately paves the way for type 2 diabetes (T2DM). However, in patients with RA, T2DM remains significantly undiagnosed or undertreated, apparently which increases the risk of developing cardio-metabolic comorbidities. This study aimed to evaluate the glycemic status among RA patients and its association with disease activity. Result One hundred fifty inpatients RA cases according to ACR/EULAR standards were included in the cross-sectional study who have an average age of 45.4±12.15 years and a median and interquartile period of RA of 2.25 years and 0.48–6 years, respectively. We discovered that 36% of people had T2DM, 26% were prediabetic, and 38% were non-diabetic. Age was shown to be significantly correlated with DM frequency in RA patients (p=0.007). There were 28 patients with elevated disease activity (19%) and 60 patients with low disease activity (40%) in this study. No substantial associations were found in the presence of DM with gender, anti-CCP, RF, disease duration, or DAS28. Conclusion RA patients are more likely to experience diabetes, and resultantly a high index of notion must be kept. Clinician should be aware about the affliction of undiagnosed diabetes and prediabetes in RA patients. Furthermore, keeping an eye on glycemic control in RA patients could prevent metabolic and cardiovascular comorbidities in those susceptible patients.
first_indexed 2024-04-11T18:41:23Z
format Article
id doaj.art-ed4f63cc07ee48f480eba31de6652c62
institution Directory Open Access Journal
issn 1110-161X
2090-3235
language English
last_indexed 2024-04-11T18:41:23Z
publishDate 2021-12-01
publisher SpringerOpen
record_format Article
series Egyptian Rheumatology and Rehabilitation
spelling doaj.art-ed4f63cc07ee48f480eba31de6652c622022-12-22T04:08:58ZengSpringerOpenEgyptian Rheumatology and Rehabilitation1110-161X2090-32352021-12-014811910.1186/s43166-021-00097-8Poor glycemic control enhances the disease activity in the RA patients with undiagnosed diabetes—a cross-sectional clinical studyPulak Kanti Palit0Ashekul Islam1Md Syeed Al Habib2Abu Syed Mohammed Mujib3Joyonti Datta4Bahni Chakraborty5Suman Dhar6Dhiman Chowdhury7Md Faisal Fahad Chowdhury8Mohammad Shawkat Ali9Arfana Yesmin10Mohammod Johirul Islam11Nishat Akther12Abdullah Al Mamun13Khairul Islam14Pradip Kumar Nath15Chittagong Medical CollegeMawlana Bhashani Science and Technology UniversityMawlana Bhashani Science and Technology UniversityUniversity of ChittagongChittagong Medical CollegeChittagong Medical CollegeChittagong Medical CollegeChittagong Medical CollegeChittagong Medical CollegeChittagong Medical CollegeChittagong Medical CollegeMawlana Bhashani Science and Technology UniversityMawlana Bhashani Science and Technology UniversityMawlana Bhashani Science and Technology UniversityMawlana Bhashani Science and Technology UniversityChittagong Medical CollegeAbstract Background Rheumatoid arthritis (RA), an autoimmune disorder, characterized by systemic inflammation and swollen joints, establishes itself as a critical threat. A pro-inflammatory cytokine TNF-α is a well-known driver of RA pathogenesis and at the same time predisposes to insulin resistance through signal impediment which ultimately paves the way for type 2 diabetes (T2DM). However, in patients with RA, T2DM remains significantly undiagnosed or undertreated, apparently which increases the risk of developing cardio-metabolic comorbidities. This study aimed to evaluate the glycemic status among RA patients and its association with disease activity. Result One hundred fifty inpatients RA cases according to ACR/EULAR standards were included in the cross-sectional study who have an average age of 45.4±12.15 years and a median and interquartile period of RA of 2.25 years and 0.48–6 years, respectively. We discovered that 36% of people had T2DM, 26% were prediabetic, and 38% were non-diabetic. Age was shown to be significantly correlated with DM frequency in RA patients (p=0.007). There were 28 patients with elevated disease activity (19%) and 60 patients with low disease activity (40%) in this study. No substantial associations were found in the presence of DM with gender, anti-CCP, RF, disease duration, or DAS28. Conclusion RA patients are more likely to experience diabetes, and resultantly a high index of notion must be kept. Clinician should be aware about the affliction of undiagnosed diabetes and prediabetes in RA patients. Furthermore, keeping an eye on glycemic control in RA patients could prevent metabolic and cardiovascular comorbidities in those susceptible patients.https://doi.org/10.1186/s43166-021-00097-8Diabetes mellitusRheumatoid arthritisGlycemic controlDAS-28RFAnti-CCP
spellingShingle Pulak Kanti Palit
Ashekul Islam
Md Syeed Al Habib
Abu Syed Mohammed Mujib
Joyonti Datta
Bahni Chakraborty
Suman Dhar
Dhiman Chowdhury
Md Faisal Fahad Chowdhury
Mohammad Shawkat Ali
Arfana Yesmin
Mohammod Johirul Islam
Nishat Akther
Abdullah Al Mamun
Khairul Islam
Pradip Kumar Nath
Poor glycemic control enhances the disease activity in the RA patients with undiagnosed diabetes—a cross-sectional clinical study
Egyptian Rheumatology and Rehabilitation
Diabetes mellitus
Rheumatoid arthritis
Glycemic control
DAS-28
RF
Anti-CCP
title Poor glycemic control enhances the disease activity in the RA patients with undiagnosed diabetes—a cross-sectional clinical study
title_full Poor glycemic control enhances the disease activity in the RA patients with undiagnosed diabetes—a cross-sectional clinical study
title_fullStr Poor glycemic control enhances the disease activity in the RA patients with undiagnosed diabetes—a cross-sectional clinical study
title_full_unstemmed Poor glycemic control enhances the disease activity in the RA patients with undiagnosed diabetes—a cross-sectional clinical study
title_short Poor glycemic control enhances the disease activity in the RA patients with undiagnosed diabetes—a cross-sectional clinical study
title_sort poor glycemic control enhances the disease activity in the ra patients with undiagnosed diabetes a cross sectional clinical study
topic Diabetes mellitus
Rheumatoid arthritis
Glycemic control
DAS-28
RF
Anti-CCP
url https://doi.org/10.1186/s43166-021-00097-8
work_keys_str_mv AT pulakkantipalit poorglycemiccontrolenhancesthediseaseactivityintherapatientswithundiagnoseddiabetesacrosssectionalclinicalstudy
AT ashekulislam poorglycemiccontrolenhancesthediseaseactivityintherapatientswithundiagnoseddiabetesacrosssectionalclinicalstudy
AT mdsyeedalhabib poorglycemiccontrolenhancesthediseaseactivityintherapatientswithundiagnoseddiabetesacrosssectionalclinicalstudy
AT abusyedmohammedmujib poorglycemiccontrolenhancesthediseaseactivityintherapatientswithundiagnoseddiabetesacrosssectionalclinicalstudy
AT joyontidatta poorglycemiccontrolenhancesthediseaseactivityintherapatientswithundiagnoseddiabetesacrosssectionalclinicalstudy
AT bahnichakraborty poorglycemiccontrolenhancesthediseaseactivityintherapatientswithundiagnoseddiabetesacrosssectionalclinicalstudy
AT sumandhar poorglycemiccontrolenhancesthediseaseactivityintherapatientswithundiagnoseddiabetesacrosssectionalclinicalstudy
AT dhimanchowdhury poorglycemiccontrolenhancesthediseaseactivityintherapatientswithundiagnoseddiabetesacrosssectionalclinicalstudy
AT mdfaisalfahadchowdhury poorglycemiccontrolenhancesthediseaseactivityintherapatientswithundiagnoseddiabetesacrosssectionalclinicalstudy
AT mohammadshawkatali poorglycemiccontrolenhancesthediseaseactivityintherapatientswithundiagnoseddiabetesacrosssectionalclinicalstudy
AT arfanayesmin poorglycemiccontrolenhancesthediseaseactivityintherapatientswithundiagnoseddiabetesacrosssectionalclinicalstudy
AT mohammodjohirulislam poorglycemiccontrolenhancesthediseaseactivityintherapatientswithundiagnoseddiabetesacrosssectionalclinicalstudy
AT nishatakther poorglycemiccontrolenhancesthediseaseactivityintherapatientswithundiagnoseddiabetesacrosssectionalclinicalstudy
AT abdullahalmamun poorglycemiccontrolenhancesthediseaseactivityintherapatientswithundiagnoseddiabetesacrosssectionalclinicalstudy
AT khairulislam poorglycemiccontrolenhancesthediseaseactivityintherapatientswithundiagnoseddiabetesacrosssectionalclinicalstudy
AT pradipkumarnath poorglycemiccontrolenhancesthediseaseactivityintherapatientswithundiagnoseddiabetesacrosssectionalclinicalstudy